KALA BIO, Inc. short interest in 2023
In 2023, KALA BIO, Inc.'s disclosed short interest ran from 15.56% of shares outstanding on 13 Jan 2023 to 2.73% on 15 Dec 2023, a change of -12.83 percentage points. The year's high was 19.97% on 31 Jan 2023 and its low 2.02% on 30 Nov 2023, averaging 7.63% across 22 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.35 days on 13 Oct 2023. Full history: KALA BIO, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 15.56% (13 Jan 2023)
- End of year
- 2.73% (15 Dec 2023)
- Change
- -12.83 pp
- High
- 19.97% (31 Jan 2023)
- Low
- 2.02% (30 Nov 2023)
- Average
- 7.63%
- Highest days to cover
- 8.35 (13 Oct 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 15.56% | 1.00 | |
| 31 Jan 2023 | 19.97% | 1.00 | |
| 15 Feb 2023 | 14.07% | 1.00 | |
| 28 Feb 2023 | 16.41% | 1.74 | |
| 15 Mar 2023 | 9.76% | 1.00 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 12.65% | 1.00 | |
| 14 Apr 2023 | 8.49% | 1.00 | |
| 28 Apr 2023 | 8.22% | 1.51 | |
| 15 May 2023 | 7.98% | 1.59 | 10-Q filed, results (8-K) |
| 31 May 2023 | 6.38% | 1.77 | |
| 15 Jun 2023 | 6.06% | 1.28 | |
| 30 Jun 2023 | 8.12% | 2.97 | |
| 14 Jul 2023 | 8.06% | 2.77 | |
| 31 Jul 2023 | 3.95% | 3.20 | |
| 15 Aug 2023 | 2.97% | 1.73 | 10-Q filed, results (8-K) |
| 15 Sep 2023 | 2.65% | 2.55 | |
| 29 Sep 2023 | 3.93% | 4.98 | |
| 13 Oct 2023 | 2.96% | 8.35 | |
| 31 Oct 2023 | 2.49% | 5.61 | |
| 15 Nov 2023 | 2.35% | 3.48 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 2.02% | 2.21 | |
| 15 Dec 2023 | 2.73% | 1.00 |
See also: KALA BIO, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.